BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9475148)

  • 21. Staging system for gestational trophoblastic tumors.
    Goldstein DP; Berkowitz RS
    J Reprod Med; 1984 Nov; 29(11):792-5. PubMed ID: 6097682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of patients with metastatic gestational trophoblastic tumor.
    Ghaemmaghami F; Behtash N; Soleimani K; Hanjani P
    Gynecol Oncol; 2004 Jul; 94(1):187-90. PubMed ID: 15262140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; CantĂș MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of 13 cases of gestational trophoblastic tumor misdiagnosed as ectopic pregnancy].
    Qian JH; Ye DF; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):91-4. PubMed ID: 15840286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
    Hoekstra AV; Keh P; Lurain JR
    J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
    Kohorn EI
    Int J Gynecol Cancer; 2001; 11(1):73-7. PubMed ID: 11285037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients.
    Lan Z; Hongzhao S; Xiuyu Y; Yang X
    Gynecol Oncol; 2001 Oct; 83(1):146-8. PubMed ID: 11585428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of gestational trophoblastic disease at a single institute.
    Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
    Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Floxuridine-containing regimens in the treatment of gestational trophoblastic tumor.
    Wan X; Yang X; Xiang Y; Wu Y; Yang Y; Ying S; Li J
    J Reprod Med; 2004 Jun; 49(6):453-6. PubMed ID: 15283053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease.
    Smith DB; Holden L; Newlands ES; Bagshawe KD
    Br J Obstet Gynaecol; 1993 Feb; 100(2):157-60. PubMed ID: 8386542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for trophoblastic disease: current standards.
    Kendall A; Gillmore R; Newlands E
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):48-54. PubMed ID: 12597349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
    Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
    Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
    Ngan HY; Tam KF; Lam KW; Chan KK
    Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of low-risk gestational trophoblastic tumors with etoposide (VP16) in patients resistant to methotrexate.
    Mangili G; Garavaglia E; Frigerio L; Candotti G; Ferrari A
    Gynecol Oncol; 1996 May; 61(2):218-20. PubMed ID: 8626136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.